Discussion
This study represents the largest consecutive case series of vitrectomies in Africa and offers insights into the clinical presentation and outcomes of this surgery. As a retrospective case series, it lacks controls that would enable it to be compared directly with outcomes in a more developed continent. Equally, the study was performed in a single centre in Nigeria and may not be generalisable to all of Africa, given the variation in ethnicity, disease and surgical practice. Additionally, collecting data from a team of surgeons, of whom two were more junior, may also have introduced interoperation variability and affected surgical outcomes. The study was also conducted over a period of 8 years, which coincidentally was a significant time globally for advancements in the vitrectomy technique, and so surgery was evolving over this time period.
Nevertheless, this paper adds a significant contribution to the literature by making available real-world outcomes, which may serve as a benchmark for others in Africa and drive the need for better outcomes and specialist training of VR surgeons and their teams.
Studies conducted in Africa report a variable incidence of VR diseases, but there are few population-based studies.7–10 In the national Nigerian blindness survey, Kyari et al found that the age-adjusted prevalence of diabetes in Nigeria was 3.25% and that over 10% of people with diabetes aged ≥40 years had sight-threatening DR.11 12 Trauma accounted for 1.1% of blindness, but retinal detachment was not specifically reported. With an ever-increasing population in Nigeria and the increasing prevalence of diabetes mellitus in Africa and worldwide, the need for retinal screening and VR services in Africa is essential.11 13 14
This study demonstrated that retinal detachment, while a low concern on a population basis, remains the most common indication for vitrectomy, with the possibility to prevent blindness. This supports the findings by Yorston et al, in 2002, who also highlighted the burden of retinal detachments and advocated for more resources and training.5 However, this study also highlighted the fact that patients with retinal detachment come on average 13.5 months after the initial onset of symptoms and only 43% of patients came within the first month. This translates to a majority of patients (97%) presenting with macular involvement. Longer duration between symptoms and treatment has long been associated with poorer visual outcomes.7 This study suggested that patients often presented only when their better eye deteriorated, as indicated by the high number of patients who had poor vision in the fellow eye for RRD, which was 28.9%, and for DR was 35%. Interestingly, regardless of indication for vitrectomy, a significantly higher proportion of males accessed VR services than females (80:20), which highlights the inequalities in healthcare access and supports the findings of the Nigerian national blindness survey which found that being female was a risk factor for blindness.15
The delay in presentation allows PVR to develop and is linked to poor prognosis. PVR was seen in a third of RRD eyes in this study and 16.5% of eyes had significant PVR (grades C and D). This is lower than what has been reported in a similar study from South Africa in which PVR was seen in 33% of the eyes.16 The study from east Africa reported a similar PVR rate of 18%.5 However, a study from Ethiopia having a much higher rate of significant PVR at 69% has been reported.6 It is therefore safe to say that PVR rates in Africa vary widely but are in the double digits, contrary to findings in the more developed countries which have single-digit PVR rates.17 18 This creates a significant challenge and complexity to retinal detachment presentation and treatment outcomes. Similarly, GRTs are more difficult to treat, and their frequency in this study (5.7%) and in Yorston’s study (8.3%) suggests that GRTs are more common in Africa than in the UK.19
The advanced presentation of African patients with RRD begs the question what surgical technique is best used in these complex cases. Several studies have tried to answer this question, arguing that using scleral buckle alone might have better anatomical success rates, but the complexity of cases with PVR would support the necessity for vitrectomy with silicone oil.20–22 In this series, vitrectomy rather than scleral buckle featured as the predominant technique, with only 5% of cases using additional buckle. Interestingly, the use of scleral buckle reduced and vitrectomy increased during the study period, similar to global trends as highlighted by the American Society of Retina Specialists (ASRS.org) Preferences and Trend (PAT) survey.
Final anatomical success was 88.3%, similar to the 88.2% reported in Kenya with patients having a similar amount of advanced PVR.5 The visual outcome of the RRD eyes in this study is rather disappointing compared with the East Africa study where 63.7% had a vision of 6/60 or better. However their visual acuity results were reported for patients who achieved anatomical success, whereas our study reports on all retinal detachments. Our poor results could also be explained by the significant delay in patient presentation; almost all patients were macular off at presentation and that nearly 40% of patients had complications from using silicone oil and as much as 41% of patients did not have the oil removed by the final clinic visit. Outcome of surgery using silicone oil has been shown to be poorer than with gas and has the added disadvantage of requiring a further procedure to remove the oil. Expansile gases are the way forward to improve vitrectomy outcomes for African patients, but collaborative efforts are needed to create reliable and affordable supply chains to VR units within Africa.
The visual outcomes in the DR were better than in the rhegmatogenous retinal detachment group, which is unsurprising given the indication in 60% of these vitrectomies was VH alone. However 40% of our patients had vision which was worse postoperatively compared with Guthrie et al,23 whose study showed only 25% of patients with worse vision postoperatively. However a quarter of patients in Guthrie et al’s study were non-domicile and may represent different ethnicity. Mastropasqua et al have shown that black patients have poorer visual outcomes compared with white and Asian patients, and this may explain our outcomes in an exclusively black population.24 A preoperative intravitreal injection of bevacizumab has been demonstrated by Guthrie et al in an African population to reduce intraoperative complications and reduce vision loss after vitrectomy.23 However the additional cost incurred by the patient remains a challenge and has not been adopted as routine in our practice.
This study highlights the challenges faced by VR teams performing vitrectomies in Africa. There is still much to be improved on surgically, including improvements in techniques, equipment and training. However, to improve outcomes from vitrectomy, patients with VR problems need to be identified earlier and expansile gases used as the tamponade. In the case of RRD, patient awareness of symptoms needs to be raised at the community level to trigger early consultation at the primary level, followed by assessment and evaluation of the eye by health professionals, who with fundal mobile photography and digital technology, can communicate and refer patients to tertiary care.25 For DR, a national screening programme of annual fundus examination for all patients with diabetes needs to be implemented to identify and treat proliferative disease early.